Long-Acting Hydrocortisone for Glucocorticoid Replacement Therapy

Publisher： Karger

E-ISSN： 1663-2826|68|5|182-188

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.68, Iss.5, 2007-12, pp. : 182-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing Medical Therapy of Acromegaly: Beneficial Effects of Cabergoline in Patients Uncontrolled with Long-Acting Release Octreotide

By  

Neuroendocrinology, Vol. 90, Iss. 1, 2009-05 ,pp. : 82-92

Karger

Access to resources Recommend Favorite

Long-Acting Lanreotide in Adolescent Girls with Constitutional Tall Stature

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 4, 2009-03 ,pp. : 228-236

Karger

Access to resources Recommend Favorite

Management of Glucocorticoid Replacement in Adult Growth Hormone Deficiency

By  

Hormone Research in Paediatrics, Vol. 67, Iss. 1, 2007-02 ,pp. : 155-164

Karger

Access to resources Recommend Favorite

Use of Long-Acting Somatostatin Analogue (Lanreotide) in an Adolescent with Diazoxide-Responsive Congenital Hyperinsulinism and Its Psychological Impact

By  

Hormone Research in Paediatrics, Vol. 84, Iss. 5, 2015-0 ,pp. : 355-360

Karger

Access to resources Recommend Favorite

Impact of Octreotide Long-Acting Release on Tumour Growth Control as a First-Line Treatment in Neuroendocrine Tumours of Pancreatic Origin

By  

Neuroendocrinology, Vol. 98, Iss. 2, 2013-08 ,pp. : 137-143

Karger

Access to resources Recommend Favorite